ADHD Drug Market: $2.7 billion
A brief report on Pharmaceutical Business Review notes the current market is $2.7 billion per year and that this is expected to rise to $3.3 billion by 2015. The article also notes: “Although ADHD drugs have demonstrated significant efficacy in improving the three main symptoms of ADHD - inattention, hyperactivity and impulsivity - none have shown efficacy in treating the cognitive deficits of ADHD.“
Given the amount of money involved its not surprising that manufacturers are keen to see as many children on Ritalin as possible.
Coverage on Myomancy.com: Ritalin May Lead To Depression in Later Life, New ADHD Drug Approved in UK
Other sites: Death From Ritalin, NIDA InfoFacts: Methylphenidate (Ritalin), Drug makers find ways to circumvent an advertising ban and promote psychiatric drugs for children, ADHD Info sponsored by Novartis, makers of Ritalin.
Find Out More:
Books:
- Ritalin Is Not The Answer: A Drug-Free, Practical Program for Children Diagnosed with ADD or ADHD
- Nature’s Ritalin for the Marathon Mind: Nurturing Your ADHD Child With Exercise
- Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders
- Talking Back to Ritalin: What Doctors Aren’t Telling You About Stimulants and ADHD
- Ritalin is Not the Answer Action Guide: An Interactive Companion to the Bestselling Drug-Free ADD/ADHD Parenting Program
June 15th, 2005
ADD / ADHD Medication, ADD / ADHD
Comments on: ADHD Drug Market: $2.7 billion
do you think children are overmedicated for finacial gains?
Posted by: matli toti July 14th, 2008 at 2:58 pm
Leave a Reply